IVA — Inventiva SA Share News
0.000.00%
Last trade - 00:00- €669.85m
- €502.00m
- €4.48m
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Inventiva Announces Last Patient Visit In Nativ3 Phase 3 Clinical Trial Of Lanifibranor In Mash
Brief: Inventiva Announces Comprehensive Capital Structure Optimization Including Debt And Equity Financing In Advance Of The Anticipated Phase 3 Readout
Brief: Inventiva Secures Up To €150 Mln Debt Financing, Extends Debt Maturity To 2030
Brief: Inventiva Says Trading In Paris Shares Temporarily Halted
Brief: Inventiva Q1 Cash Position At Eur 75 mln
Brief: Inventiva Says Co Names Axel-Sven Malkomes Joins As Chief Financial Officer,
France's Inventiva 2025 revenue halves on lower licensing income, net loss widens sharply
Brief: Inventiva FY Operating Income EUR -141.013 Million
France's Inventiva prelim 2025 revenue misses analyst expectations
Brief: Inventiva FY Revenue EUR 4.5 Mln
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Europe Research Roundup: BAWAG Group, Enka Insaat, Partners Group Holding
Kempen starts Inventiva with 'buy' citing encouraging liver disease drug trial results
French and Benelux stocks-Factors to watch
Brief: Inventiva Announces Trading Resumption Of Its Ordinary Shares On Euronext Paris
Brief: Inventiva Announces Trading Resumption On Euronext Paris
Brief: Inventiva SA Files For Stock Shelf Of Up To $300 Million
Brief: Inventiva Announces The Implementation Of A New ATM Program